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Abstract 
Apoptosis is a form of programmed cell death leading to genetically controlled self-destruction of cells. It is 
essential in the development, maintenance, and regulation of cells during physiological as well as pathological 
conditions. Deregulation of apoptotic mechanisms is associated with various pathological diseases including 
cancer, autoimmune disorders, viral and bacterial infections. Virus and Mycobacterium tuberculosis elicit host cell 
apoptosis as a part of host immune defense or pathogen dissemination. They inhibit both extrinsic and intrinsic 
pathways of apoptotic mechanisms facilitating pathogen survival and escape from host immune defense.  
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Introduction 
Apoptosis is a form of programmed cell death 
which is the most common form of physiological 
cell death in eukaryotes, evolutionarily conserved 
from yeast to humans.  It leads to the genetically 
controlled sequence of events that eventually give 
rise to spatially and temporally regulated self-
destruction of cells [1,2]. Apoptotic mode of cell 
death is an active process, critical in the 
development of multicellular organisms and the 
maintenance and regulation of cell populations 
during physiological and pathological conditions 
[3,4]. Deregulation of apoptosis leads to various 
pathological conditions including cancer, 
autoimmune disorders, and spreading of viral 
infections while AIDS, Neurodegenerative 
disorders, and ischemic diseases are caused or 
enhanced by accelerated apoptosis [3,5–8]. Both 
viral and Mycobacterium tuberculosis (Mtb) 
infections modulate host cell apoptosis for their 
benefits [6,9–11]. This review briefly summarizes 
the mechanisms of apoptotic deaths and their 
regulation and significances in viral and 
mycobacterial infections.  
Apoptosis 
Various extracellular and intracellular stimuli 
trigger apoptosis. Ligation of cell surface 
receptors, DNA damage (because of defects in 
DNA repair mechanism, cytotoxic drugs, or 
irradiation), lack of survival signals, contradictory 
cell cycle signaling or developmental death signals 
are some of the signals evoking apoptosis [1]. 
Apoptosis depends on the activation of a 
proteolytic cascade of pro-caspases into active 
caspases. These caspases are synthesized in cells 
as inactive zymogens called as pro-caspases. Pro-
caspases are cleaved by pre active caspases at one 
or two specific aspartic acids splitting them into 
two subunits, one small and another large. The 
assembly of two heterodimers of small and large 
subunits results in the formation of active 
caspases. The pro-caspases fall into two classes- 
initiator and executioner [12,13]. Apoptotic stimuli 
trigger activation of initiator caspases (caspases 2, 
8, 9, 10) which in turn cleave and activate the 
executioner caspases (caspases 3, 6, 7) [14]. The 
executioner caspases cleave thousands of 
substrates responsible for the characteristic 
morphological and biochemical features of 
apoptotic cells [14]. The three main established 
routes of apoptosis in mammals are extrinsic, 
intrinsic and perforin/granzyme pathways [2,15]. 
Irrespective of the death stimuli or apoptotic 
paths, all the three routes lead to the activation of 
executioner caspases 3, 6 and 7 (Figure 1).  
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Figure 1. Diagram showing general apoptosis process through three main pathways: Extrinsic (death receptor-
mediated viz. FasL, Fas, Trail-R1, and R2) pathway, intrinsic (mitochondria-dependent) pathway and perforin 
(granzyme)-mediated pathway. The extrinsic pathway starts with the binding of death receptor ligand (DR ligand) to 
the cell surface death receptors including tissue necrosis factor (TNF) receptor superfamily include CD95 and TNF-
related apoptosis-inducing ligand (TRAIL)-R1/-R2, with the rapid activation of the initiator caspase 8. In the intrinsic 
pathway, stress (reactive oxygen species, ROS, UV, genotoxic stress, etc.) results in the perturbation of mitochondria 
membrane permeability, release of the proteins such as cytochrome c from the inner mitochondrial membrane space. 
The release is regulated in part by Bcl2 family members, with anti-apoptotic (Bcl2/Bcl—XL/Mcl1) and pro-apoptotic 
(Bax, Bak, and tBid). Once released, cytochrome c binds to apoptotic protease-activating factor 1 (Apaf1), which results 
in the formation of the Apaf1-caspase 9 apoptosome complex and activation of the initiator caspase 9. The activated 
initiator Caspases 8 and 9 then activate the effector caspase 3, 6 and7 with normal cell apoptosis or another T-cell 
effector mechanism. Cytotoxic T lymphocytes (CTL) or natural killer (NK) cells secrete the transmembrane pore-
forming molecule perforin and release cytoplasmic granules (Granzyme A/B) into tumor cells or virus-infected cells. 
Granzyme A activates DNA degradation by DNase NM23-H1while granzyme B cleaves pro-caspase 8, pro-caspase 3 or 
Bid. 
Extrinsic pathway of apoptosis 
External apoptotic signaling mediates the 
activation of transmembrane death receptors that 
transmit apoptotic signals after binding to 
extracellular death ligands such as FasL or tumor 
necrosis factor-α (TNFα) [16]. Death receptors 
belong to tumor necrosis factor receptor (TNFR) 
superfamily including TNFR-1, Fas/CD95 and 
TNF receptor-related apoptosis-inducing ligand 
(TRAIL) receptors DR-4 and DR-5 [17]. Proteins of 
TNFR family result in trimerization and activation 
of intracellular death domain after ligand binding. 
Adaptor proteins like FADD or TRADD get 
recruited through their death domains to the 
death domains of activated death receptors 
forming death inducing silencing complex (DISC). 
Death effector domains of FADD or TRADD 
recruit pro-caspase 8 leading to their autocatalytic 
activation and release of active caspase 8. 
Activated caspase 8 then cleaves and activates 
downstream executioner caspases 3 and 7. In some 
cases, the extrinsic death signals can crosstalk with 
an intrinsic pathway through caspase 8-mediated  
proteolysis of the BH3-only protein Bid. Truncated 
Bid can translocate to mitochondria and induce 
the release of cytochrome c and assembly of 
apoptosome triggering activation of pro-caspase 9 
[18–20] (Figure 1). 
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Intrinsic pathway of apoptosis 
Intracellular death signals such as DNA damage, 
oxidative stress, starvation and others trigger 
intracellular apoptotic pathway. All of these 
stimuli cause changes in inner mitochondrial 
membrane resulting in the opening of the 
mitochondrial permeability transition (MPT) pore, 
loss of the mitochondrial transmembrane potential 
(ΔΨm) and release of two groups of pro-apoptotic 
proteins from the intermembrane space into the 
cytosol [21]. The first group of released proteins 
constitutes cytochrome c, Smac/DIABLO, and the 
serine protease HtrA2/Omi that promotes 
caspase-dependent mitochondrial pathway [22–
24]. Cytochrome c binds and activates Apaf-1 
(apoptosis protease activating factor 1) which 
hydrolyzes bound dATP to dADP. Replacement of 
dADP with dATP/ATP leads to Apaf-1-
cytochrome c complex to oligomerize into a wheel 
like a heptamer called apoptosome. Pro-caspase 9 
gets recruited in the apoptosome through its 
caspase recruitment domain (CARD) [25] and gets 
activated and cleaved which then triggers 
activation of downstream executioner caspases 
(Figure 1) [25]. Smac/DIABLO and the serine 
protease HtrA2/Omi, on the other hand promote 
apoptosis by inhibiting IAP (inhibitors of 
apoptosis) proteins [23,24]. The second group of 
released proteins includes AIF, endonuclease G, 
and CAD which translocate to the nucleus and 
cause DNA fragmentation and condensation of 
peripheral nuclear chromatin [26–28]. In addition 
to the release of mitochondrial factors, the loss of 
the ΔΨm leads to regulation of biochemical 
homeostasis of the cell viz. ATP synthesis gets 
stopped, redox molecules like NADH, NADPH 
and glutathione are oxidized, and reactive oxygen 
species are enhanced [29–32]. 
Perforin/ Granzyme pathway of 
apoptosis 
Cytotoxic T lymphocytes (CTL) or natural killer 
(NK) cells can exert their cytotoxic effects on 
tumor cells and virus-infected cells by secretion of 
the transmembrane pore-forming molecule 
perforin with the subsequent release of 
cytoplasmic granules through the pore into the 
target cell [33]. These granules constitute the 
serine proteases granzyme A and B. Granzyme B 
can cleave proteins at aspartate residues and thus 
activate pro-caspase 8 and Bid.  Direct activation 
of pro-caspase 3 and cleavage of ICAD could also 
be the results of granzyme B. Thus granzyme B 
dependent routes of apoptosis may be 
mitochondrial or direct [26]. Granzyme A activates 
caspase-independent apoptosis [34] (Figure 1). 
Inside the cell, it enables DNA degradation by 
DNase NM23-H1. Granzyme A cleaves SET 
complex (nucleosome assembly protein that 
usually inhibits DNase NM23-H1 gene) thereby 
releasing the inhibition of DNase NM23-H1 
leading to DNA degradation [34]. 
Regulation of apoptosis 
The components of apoptotic pathways are 
genetically encoded and ready for action. Most 
cells are just waiting for the death stimuli to 
trigger these pathways. Thus a tight regulation of 
apoptosis is mandatory. B-cell lymphoma-2 (Bcl-2) 
family proteins play a crucial role in the regulation 
of apoptosis through their ability to control 
mitochondrial permeability [35]. Bcl-2 family 
comprises three subfamilies that contain between 
one and four Bcl-2 homology (BH) domains. Anti-
apoptotic Bcl-2 subfamily includes four BH 
domains, and most of them are membrane-
associated proteins. The pro-apoptotic Bax-like 
subfamily comprises membrane-associated 
proteins that lack BH4 domains, while the BH3-
only subfamily includes a diverse group of 
proteins containing only BH3 domains [36].  The 
mammalian BH3-only protein family currently 
consists of eight members (Bid, Bad, Bim, Bak, Bik, 
NOXA, PUMA, and HRK). Among eight 
members, NOXA, PUMA, and Bid are 
transcriptionally upregulated by p53. Bid is 
activated by caspase 8-dependent proteolysis. 
Phosphorylated Bad is trapped by 14-3-3 protein 
and sequestered in the cytoplasm. Once Bad is 
unphosphorylated, it gets freed and is 
translocated to mitochondria. Bim and BMF are 
microtubules, and actin microfilaments tethered 
proteins and disruption of cytoskeleton liberates 
them [37,38]. The anti-apoptotic Bcl-2 family of 
proteins (Bcl-2, Bcl-XL, Bcl-W, Mcl1, Bcl2A1 and 
Bcl-B) blocks apoptosis by preventing BH3-only  
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Table 1: List of viral and Mtb proteins involved in apoptosis deregulation 
Viruses/Mtb (proteins) Modulation in apoptotic process References 
Adenovirus proteins (E3-10.4K  
and E3-14.5K) 
Reduce Fas presentation, inhibit TNF-mediated apoptosis 
 
[42, 43] 
 
Epstein-Barr virus LMP-1 protein Acts like constitutively activated TNF receptor [44] 
Myxoma virus protein M-T2 Viral mimic protein of TNF receptor [45] 
Cowpox virus CRM protein Prevents TNF-mediated apoptosis [46] 
Vaccinia virus protein A53R Prevents TNF-mediated apoptosis [47] 
HIV-1 Tat Decreases susceptibility to TRAIL, TNFα, and Fas. 
Upregulates FasL, Bax, caspase 8 and RCAS-1 expression, 
upregulates Bcl2 and c-FLIP expression, downregulates 
caspase 10 expression 
[50,68-72] 
Herpesviruses: FLICE Inhibits DISC formation [51] 
Human Cytomegalovirus: vICA Inhibits caspase 8 [52] 
SV40 virus large T antigen Binds to and sequesters p53  [53] 
Human papillomavirus E6 protein p53 ubiquitination and degradation [55] 
Adenovirus E1B-55K protein p53 ubiquitination and degradation [56] 
Adenovirus E1B-19K Binds to Bak preventing Bax-Bak oligomerization [56] 
Human herpesviruses: Bcl-2 ortholog Blocks the mitochondrial release of cytochrome c [59] 
Epstein-Barr virus: Bcl-2 ortholog Blocks the mitochondrial release of cytochrome c [60] 
Kaposi’s sarcoma-associated γ-herpes 
virus: Bcl-2 ortholog 
Blocks the mitochondrial release of cytochrome c [59] 
Human CMV protein: vMIA Inhibits Fas-mediated apoptosis [61,62] 
Poxviruses serpin CrmA Suppresses caspase 1 and 8, inhibits TNF and Fas-mediated 
apoptosis 
[63] 
Baculovirus protein p35 Inhibits caspases 1, 3, 6, 7, 8 and 10 [64,65] 
African swine flu virus: vIAP Inhibits caspase 3 [66] 
HIV-1 gp120 Syncytia formation, upregulates Fas, FasL, and TNFα 
expression, upregulates TRAIL receptors: DR4 and DR5, acts 
as a molecular mimic of Fas, reduces expression of Bcl2,  
phosphorylates mTOR and p53, increases expression of 
PUMA and activates p38 
[48,67] 
HIV-1 Nef Increases the membrane expression of TNF [49] 
Hepatitis B virus pX protein  Inactivates p53 [57] 
West Nile capsid protein Binds to and sequesters p53 [54] 
Arenaviruses matrix protein Z Activation of BH3-only proteins?, an indirect interaction 
with p53 and PI3K/Akt with the help of PML? 
[74-78] 
Enterovirus 71 2B protein Direct interaction with and activation of Bax [80,81] 
Mtb proteins 
(Mcl-1, A1?) 
Upregulates TNF, Fas, and caspase 8 expression, stimulates 
ROS-dependent activation of apoptosis signal-regulating 
kinase, phosphorylates and degrades FLIP, MOMP-
mediated apoptosis, upregulates FLIP expression, secretes 
more sTNFR2, increases expression of anti-apoptotic protein 
Bcl-w, inhibition of the pro-apoptotic protein Bad 
[101,104-
106, 113-
115] 
? Refers to mechanism not yet verified.   
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protein induced oligomerization of the pro-
apoptotic Bcl-2 proteins Bax and Bak in the 
mitochondrial outer membrane. Some BH3-only 
proteins (Bid and Bim) interact with almost all 
anti-apoptotic Bcl-2 proteins whereas others 
(NOXA) interact only with specific Bcl-2 members 
[35,37,38]. 
 In conclusion, under distinct apoptotic stress 
signals, BH3-only proteins interfere the fine-tuned 
balance of homo or hetero-oligomerization 
between pro-apoptotic members Bax/Bak and 
anti-apoptotic members Bcl-2/Bcl-XL and release 
the intermembrane space proteins like cytochrome 
c to trigger apoptosis.IAPs (inhibitors of apoptosis 
proteins) are a family of proteins having anti-
apoptotic activity [32]. Including NAIP, c-IAP1, c-
IAP2, XIAP, and survivin, there are eight human 
IAP homologs. XIAP, c-IAP1, and c-IAP2 directly 
inhibit caspases 3, 7, and 9. Smac/Diablo, when 
released from mitochondria, binds to XIAP and 
releases caspases from XIAP-caspase complex 
thereby enabling their activation [39,40]. The 
cellular FLICE-like inhibitory proteins (c-FLIPs) 
inhibit activation of caspase 8 and thus prevent 
apoptosis [34]. 
Virus-mediated modulation of apoptosis 
In most cases of viral infections, immune and 
inflammatory responses, as well as apoptosis of 
the infected host cell, are triggered. Meanwhile, 
some viruses utilize apoptosis as a mechanism of 
killing cells and spreading virus by targeting a 
variety of crucial steps in the pathways that block 
or delay apoptosis. Thus viral infection elicits host 
cell apoptosis as a part of host immune defense or 
viral survival component [41]. 
Virus modulates the extrinsic pathway 
of apoptosis 
Many viruses can efficiently modulate the 
extrinsic pathway of apoptosis.  Adenovirus 
proteins E3-10.4K and E3-14.5K reduce the 
presentation of Fas molecules on the surface of the 
cells that results in resistance to Fas-mediated cell 
death [42]. These proteins also resist TNF-
mediated apoptosis [43]. Epstein-Barr virus LMP-1 
(latent membrane-1) protein acts like 
constitutively activated TNF receptor which 
interacts with TNF receptor-associated death 
domain (TRADD) protein [44]. The myxoma virus 
protein M-T2, a viral mimic protein of TNF 
receptor, Cowpox virus cytokine response 
modifying (CRM) proteins and vaccinia virus 
protein A53R inhibits TNF-mediated apoptosis 
[45, 46, 47]. Membrane-bound HIV-1 gp120 
induces apoptosis through syncytia formation 
while it triggers apoptosis by various mechanisms 
like upregulation of Fas, FasL, and TNFα 
expression, upregulation of TRAIL receptors DR4 
and DR5, and acting as a molecular mimic of Fas 
[48]. HIV-1 Nef protein downregulates the 
expression of CD4 and MHC I molecules but 
heightens the membrane expression of TNF and 
related cytokines [49]. HIV-1 Tat mediates 
apoptotic resistance in the infected cells by 
decreasing susceptibility to TRAIL, TNFα, and 
Fas, but it reconciles apoptosis in uninfected 
bystander cells by upregulation of FasL [50]. 
Various herpes viruses encode viral FLICE-like 
inhibitory proteins (FLIPs), which contain death 
effector domain but lack caspase activity, inhibit 
extrinsic apoptotic pathway at the point of DISC 
formation [51]. The human cytomegalovirus 
encodes vICA, which associates with caspase 8 
and blocks its activation [52] (Table 1). 
Virus modulates the intrinsic pathway of 
apoptosis 
Many viruses alter apoptosis utilizing the tumor 
suppressor p53. SV40 virus large T antigen and 
West Nile capsid protein binds to p53 and 
sequesters it in an inactive complex [53,54]. 
Moreover, Human papillomavirus E6 protein and 
adenovirus E1B-55K protein promote ubiquitin 
mediated degradation of p53 [55,56] and Hepatitis 
B virus pX protein binds and inactivates p53 [57]. 
Virus-encoded orthologs of anti-apoptotic Bcl2 
proteins are also crucial players in the modulation 
of apoptosis. Adenovirus E1B-19K is similar to 
Bcl2 which binds to Bak preventing Bax-Bak 
oligomerization [58]. Human herpes viruses, 
Epstein-Barr virus and Kaposi’s sarcoma-
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associated γ-herpes virus use Bcl-2 orthologs to 
block the mitochondrial release of cytochrome c 
[59,60]. Although human cytomegalovirus (CMV) 
protein vMIA shares no sequence homology to 
Bcl2, it is functionally similar to Bcl-2 and inhibits 
Fas-mediated apoptosis [61,62]. Some viruses use 
IAP orthologs that can inhibit caspases. For 
example, Poxviruses serpin CrmA suppresses 
caspase 1 and 8 and inhibits TNF and Fas-
mediated apoptosis [63]. Likewise, African swine 
flu virus produces vIAP that inhibits caspase 3 
and Baculovirus protein p35 is another vIAP with 
a potential to inhibit caspases 1, 3, 6, 7, 8 and 10 
[64,65,66]. HIV-1 gp120 triggers apoptosis by 
reduced expression of Bcl2, phosphorylation of 
mTOR and p53, increased expression of pro-
apoptotic protein PUMA and activation of p38 
[67]. HIV-1 Tat inhibits apoptosis in infected cells 
by upregulation of Bcl2 and c-FLIP expression 
[68,69] and downregulation of caspase 10 
expression [70]. The same protein triggers 
apoptosis in bystander cells by upregulation of 
Bax, caspase 8 and RCAS-1 expression [71,72], and 
Bim-mediated intrinsic apoptosis [73]. Matrix 
protein Z of some arenaviruses (New World 
arenavirus, Tacarible virus (TCRV), and the 
attenuated vaccine strain of Junín virus (JUNV) 
Candid #1)  activates caspase 9 thereby triggering 
the intrinsic apoptotic pathway [74,75]. Though 
the exact molecular mechanism of viral protein Z-
mediated apoptosis is still not clear, in vitro 
experiments suggest a direct activation of BH3-
only proteins and an indirect interaction with 
proteins like p53 and PI3K/Akt through cellular 
oncoprotein promyelocyte leukemia protein 
(PML) [74–76]. The Old World arenaviruses, the 
lymphocytic choriomeningitis virus (LCMB) and 
Lassa virus (LASV) do not cause apoptosis of 
infected cells [77,78]. Caspase-mediated cleavage 
of nucleoproteins (NPs) of Old World 
areanviruses generates multiple truncated 
isoforms of NPs [74,79]. A decoy function of NPs 
has been proposed in which the cleavage of highly 
expressed NPs within the cell suppresses the 
cellular targets of caspases thereby inhibiting the 
apoptosis of the infected cell [74]. Enterovirus 71 
2B protein directly interacts with and activates the 
proapoptotic protein Bax leading to the activation 
of mitochondrial pathway of apoptosis [80,81] 
(Table 1). 
Mycobacterium-mediated modulation of 
apoptosis 
Bacterial pathogens are known to have anti-
apoptotic mechanisms. Mycobacterium tuberculosis 
(Mtb) causes persistent infection indicating that it 
employs effective mechanisms to inhibit host cell 
death [82]. Published studies highlight both pro-
apoptotic as well as anti-apoptotic capabilities of 
virulent Mtb [83,84], however the underlining 
molecular mechanisms are still not well 
understood. Though there is a lack of published 
data favoring Mtb-mediated apoptosis of host 
cells, increased apoptosis of primary human 
macrophages or human macrophage-like cell lines 
(U937 and THP1) were reported upon infection 
with virulent Mtb in vitro [85–87]. Human alveolar 
macrophage-derived from bronchoalveolar lavage 
of tuberculosis patients also showed increased 
apoptotic death compared to healthy subjects 
[88,89]. Apoptosis of Mtb infected cells 
accompanied by the recruitment of uninfected 
macrophages through upregulation of MMP9 on 
epithelial cells surrounding the granuloma helps 
in the dissemination of the bacteria [90]. In the 
studies involving the zebrafish and mouse lung 
models, the pro-apoptotic nuoG Mtb mutant 
induced enhance innate response, longer survival 
and rapid dissemination of the bacteria [91,92]. 
Thus, evidence suggests that host cell apoptosis is 
crucial for host resistance to Mtb infection. 
Considerable less apoptosis of human alveolar 
macrophage or macrophage-like cell lines when 
infected with virulent Mtb compared to infection 
with less virulent strains was reported [93–96]. 
Furthermore, fact that inhibition of apoptosis of 
human and murine macrophages by Apoptosis-
inducing species M. kansaii after over-expression 
of Mtb-nuoG/SecA2/PknE [97–99] and resistance 
to FasL and TNFα-mediated apoptosis of Mtb 
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infected cells provide the evidence that Mtb 
inhibits host cell apoptosis [100].  
Mtb modulates the extrinsic pathway of 
apoptosis 
Gene expression profiling study suggests that 
numerous apoptosis-related genes are down-
regulated in active tuberculosis patients compared 
to latently infected subjects. Though expressions 
of TNF, Fas, and caspase 8 upregulate in active 
tuberculosis patients, simultaneous marked 
expression of FLIP, inhibits host cell apoptosis 
[101]. Mtb infected macrophages are known to 
secrete more soluble TNF receptor 2 (sTNFR2) 
which binds to TNFα thereby inhibiting its 
binding with the TNFR1 [100,102–104]. Upon 
infection with Mtb, TNF production in the mouse 
cell line RAW264 stimulates ROS-dependent 
activation of apoptosis signal-regulating kinase 
thereby phosphorylating FLIP [105]. Ubiquitin-
proteasome-mediated degradation of 
phosphorylated FLIP activates caspase 8 leading 
to apoptosis [105] (Table 1). 
Mtb modulates the intrinsic pathway of 
apoptosis 
Mtb infection upregulates the expression of anti-
apoptotic genes like mcl-1 and A1, both of which 
encodes for anti-apoptotic Bcl-2-like proteins [106–
110]. Alternative splicing gives rise to two 
isoforms of Myloid cell leukemia-1 (Mcl-1) 
protein. One is the anti-apoptotic full length Mcl-
1L that possesses BH domains 1, 2 and 3 and a 
transmembrane domain. Another is the pro-
apoptotic short variant Mcl-1S that lacks BH1, BH2 
and the transmembrane domain. Mcl-1S dimerizes 
with and antagonizes the function of Mcl-1L 
thereby regulates the mitochondrial permeability 
[109,111]. Furthermore, chemical inhibition of Mcl-
1 in mouse peritoneal macrophages infected with 
Mtb significantly triggered apoptosis [112]. It will 
be interesting to dissect the role of both isoforms 
of Mcl-1 in Mtb-mediated apoptosis evasion. Also, 
the expression of anti-apoptotic protein Bcl-w gets 
upregulated [113], while the inactivation of the 
pro-apoptotic Bad protein occurs upon Mtb-
H37Rv infection [114]. Infection of macrophages 
with attenuated Mtb leads to MOMP-mediated 
apoptosis without MPT induction [10,115] (Table 
1). In contrast, macrophages infected with virulent 
Mtb induce both MOMP and MPT causing 
irreversible mitochondrial swelling leading to 
necrosis [115].   
Conclusion 
Programmed cell death via apoptosis is crucial in 
maintaining cells in health and pathological 
conditions. Both viral and Mtb infections 
modulate the apoptotic pathways of infected as 
well as neighboring bystander cells. Though the 
majority of virally infected cells undergo 
apoptosis favoring viral dissemination, viral 
proteins help specific host cells to evade apoptosis 
thereby preferring viral persistence. Mtb infection 
prominently evades host cell apoptosis leading to 
the persistent survival of the pathogen. 
Understanding the molecular mechanisms of 
deregulation of apoptosis in viral and Mtb 
infection may provide insights into revealing new 
targets for curing these pathological conditions.  
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